J1830 HCPCS Level II code: Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when…
J1830 is the HCPCS code for “Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1830Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
Short description: Interferon beta-1b / .25 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J1830 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 1982
Where J1830 sits
- 1J codesDrugs administered other than orally
- 2Active code J1830Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1830 mean?
J1830 is the HCPCS code for “Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1830?
CMS lists J1830’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1830
All J codesJ1814Insulin (lyumjev), per 5 unitsJ1815Injection, insulin, per 5 unitsJ1817Insulin for administration through dme (i.e., insulin pump) per 50 unitsJ1818Injection, pegzilarginase-nbln, 0.05 mgJ1823Injection, inebilizumab-cdon, 1 mgJ1826Injection, interferon beta-1a, 30 mcgJ1833Injection, isavuconazonium, 1 mgJ1834Injection, isoniazid, 1 mgJ1835Injection, itraconazole, 50 mgJ1836Injection, metronidazole, 10 mgJ1837Injection, posaconazole, 1 mgJ1840Injection, kanamycin sulfate, up to 500 mg